Lentiviral gene therapy reverts GPIX expression and phenotype in Bernard-Soulier syndrome type C.
Saved in:
| Title: | Lentiviral gene therapy reverts GPIX expression and phenotype in Bernard-Soulier syndrome type C. |
|---|---|
| Authors: | Martinez-Navajas G; GENyO, Pfizer-Universidad de Granada-Junta de Andalucia Centre for Genomics and Oncological Research, PTS, Granada, Avenida de la Ilustracion 114, 18016 Granada, Spain.; University of Granada, Department of Biochemistry and Molecular Biology I, Faculty of Science, Avenida Fuentenueva S/n, 18071 Granada, Spain., Ceron-Hernandez J; GENyO, Pfizer-Universidad de Granada-Junta de Andalucia Centre for Genomics and Oncological Research, PTS, Granada, Avenida de la Ilustracion 114, 18016 Granada, Spain.; University of Granada, Department of Biochemistry and Molecular Biology I, Faculty of Science, Avenida Fuentenueva S/n, 18071 Granada, Spain., Simon I; GENyO, Pfizer-Universidad de Granada-Junta de Andalucia Centre for Genomics and Oncological Research, PTS, Granada, Avenida de la Ilustracion 114, 18016 Granada, Spain.; University of Granada, Department of Biochemistry and Molecular Biology I, Faculty of Science, Avenida Fuentenueva S/n, 18071 Granada, Spain., Lupiañez P; GENyO, Pfizer-Universidad de Granada-Junta de Andalucia Centre for Genomics and Oncological Research, PTS, Granada, Avenida de la Ilustracion 114, 18016 Granada, Spain.; University of Granada, Department of Biochemistry and Molecular Biology I, Faculty of Science, Avenida Fuentenueva S/n, 18071 Granada, Spain., Diaz-McLynn S; GENyO, Pfizer-Universidad de Granada-Junta de Andalucia Centre for Genomics and Oncological Research, PTS, Granada, Avenida de la Ilustracion 114, 18016 Granada, Spain., Perales S; GENyO, Pfizer-Universidad de Granada-Junta de Andalucia Centre for Genomics and Oncological Research, PTS, Granada, Avenida de la Ilustracion 114, 18016 Granada, Spain.; University of Granada, Department of Biochemistry and Molecular Biology I, Faculty of Science, Avenida Fuentenueva S/n, 18071 Granada, Spain.; Instituto de Investigación Biosanitaria Ibs.GRANADA, Granada, Spain., Modlich U; Department of Gene and Cell Therapy, Institute of Regenerative Medicine, University of Zürich, Wagistrasse 12, 8952 Schlieren-Zürich, Switzerland., Guerrero JA; Department of Haematology, University of Cambridge, Cambridge, UK.; National Health Service Blood and Transplant, Cambridge Biomedical Campus, Cambridge, UK., Martin F; GENyO, Pfizer-Universidad de Granada-Junta de Andalucia Centre for Genomics and Oncological Research, PTS, Granada, Avenida de la Ilustracion 114, 18016 Granada, Spain.; University of Granada, Department of Biochemistry and Molecular Biology III and Immunology, Faculty of Medicine, Avenida Ilustracion S/n, 18016 Granada, Spain., Sevivas T; Serviço de Sangue, Medicina Transfusional e Imunohemoterapia Do Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal., Lozano ML; Servicio de Hematología y Oncología Médica, Hospital Universitario Morales Meseguer, Centro Regional de Hemodonación, Universidad de Murcia, IMIB-Pascual Parrilla, CIBERER-ISCIII, U765 Murcia, Spain., Rivera J; Servicio de Hematología y Oncología Médica, Hospital Universitario Morales Meseguer, Centro Regional de Hemodonación, Universidad de Murcia, IMIB-Pascual Parrilla, CIBERER-ISCIII, U765 Murcia, Spain.; Grupo Español de Alteraciones Plaquetarias Congénitas (GEAPC), Madrid, Spain., Ramos-Mejia V; GENyO, Pfizer-Universidad de Granada-Junta de Andalucia Centre for Genomics and Oncological Research, PTS, Granada, Avenida de la Ilustracion 114, 18016 Granada, Spain., Tersteeg C; Laboratory for Thrombosis Research, IRF Life Sciences, KU Leuven Campus Kulak Kortrijk, Kortrijk, Belgium., Real PJ; GENyO, Pfizer-Universidad de Granada-Junta de Andalucia Centre for Genomics and Oncological Research, PTS, Granada, Avenida de la Ilustracion 114, 18016 Granada, Spain.; University of Granada, Department of Biochemistry and Molecular Biology I, Faculty of Science, Avenida Fuentenueva S/n, 18071 Granada, Spain.; Instituto de Investigación Biosanitaria Ibs.GRANADA, Granada, Spain. |
| Source: | Molecular therapy. Nucleic acids [Mol Ther Nucleic Acids] 2023 Jun 12; Vol. 33, pp. 75-92. Date of Electronic Publication: 2023 Jun 12 (Print Publication: 2023). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Cell Press Country of Publication: United States NLM ID: 101581621 Publication Model: eCollection Cited Medium: Print ISSN: 2162-2531 (Print) Linking ISSN: 21622531 NLM ISO Abbreviation: Mol Ther Nucleic Acids Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 37416759 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Lentiviral gene therapy reverts GPIX expression and phenotype in Bernard-Soulier syndrome type C. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Martinez-Navajas+G%22">Martinez-Navajas G</searchLink>; GENyO, Pfizer-Universidad de Granada-Junta de Andalucia Centre for Genomics and Oncological Research, PTS, Granada, Avenida de la Ilustracion 114, 18016 Granada, Spain.; University of Granada, Department of Biochemistry and Molecular Biology I, Faculty of Science, Avenida Fuentenueva S/n, 18071 Granada, Spain.<br /><searchLink fieldCode="AU" term="%22Ceron-Hernandez+J%22">Ceron-Hernandez J</searchLink>; GENyO, Pfizer-Universidad de Granada-Junta de Andalucia Centre for Genomics and Oncological Research, PTS, Granada, Avenida de la Ilustracion 114, 18016 Granada, Spain.; University of Granada, Department of Biochemistry and Molecular Biology I, Faculty of Science, Avenida Fuentenueva S/n, 18071 Granada, Spain.<br /><searchLink fieldCode="AU" term="%22Simon+I%22">Simon I</searchLink>; GENyO, Pfizer-Universidad de Granada-Junta de Andalucia Centre for Genomics and Oncological Research, PTS, Granada, Avenida de la Ilustracion 114, 18016 Granada, Spain.; University of Granada, Department of Biochemistry and Molecular Biology I, Faculty of Science, Avenida Fuentenueva S/n, 18071 Granada, Spain.<br /><searchLink fieldCode="AU" term="%22Lupiañez+P%22">Lupiañez P</searchLink>; GENyO, Pfizer-Universidad de Granada-Junta de Andalucia Centre for Genomics and Oncological Research, PTS, Granada, Avenida de la Ilustracion 114, 18016 Granada, Spain.; University of Granada, Department of Biochemistry and Molecular Biology I, Faculty of Science, Avenida Fuentenueva S/n, 18071 Granada, Spain.<br /><searchLink fieldCode="AU" term="%22Diaz-McLynn+S%22">Diaz-McLynn S</searchLink>; GENyO, Pfizer-Universidad de Granada-Junta de Andalucia Centre for Genomics and Oncological Research, PTS, Granada, Avenida de la Ilustracion 114, 18016 Granada, Spain.<br /><searchLink fieldCode="AU" term="%22Perales+S%22">Perales S</searchLink>; GENyO, Pfizer-Universidad de Granada-Junta de Andalucia Centre for Genomics and Oncological Research, PTS, Granada, Avenida de la Ilustracion 114, 18016 Granada, Spain.; University of Granada, Department of Biochemistry and Molecular Biology I, Faculty of Science, Avenida Fuentenueva S/n, 18071 Granada, Spain.; Instituto de Investigación Biosanitaria Ibs.GRANADA, Granada, Spain.<br /><searchLink fieldCode="AU" term="%22Modlich+U%22">Modlich U</searchLink>; Department of Gene and Cell Therapy, Institute of Regenerative Medicine, University of Zürich, Wagistrasse 12, 8952 Schlieren-Zürich, Switzerland.<br /><searchLink fieldCode="AU" term="%22Guerrero+JA%22">Guerrero JA</searchLink>; Department of Haematology, University of Cambridge, Cambridge, UK.; National Health Service Blood and Transplant, Cambridge Biomedical Campus, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Martin+F%22">Martin F</searchLink>; GENyO, Pfizer-Universidad de Granada-Junta de Andalucia Centre for Genomics and Oncological Research, PTS, Granada, Avenida de la Ilustracion 114, 18016 Granada, Spain.; University of Granada, Department of Biochemistry and Molecular Biology III and Immunology, Faculty of Medicine, Avenida Ilustracion S/n, 18016 Granada, Spain.<br /><searchLink fieldCode="AU" term="%22Sevivas+T%22">Sevivas T</searchLink>; Serviço de Sangue, Medicina Transfusional e Imunohemoterapia Do Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal.<br /><searchLink fieldCode="AU" term="%22Lozano+ML%22">Lozano ML</searchLink>; Servicio de Hematología y Oncología Médica, Hospital Universitario Morales Meseguer, Centro Regional de Hemodonación, Universidad de Murcia, IMIB-Pascual Parrilla, CIBERER-ISCIII, U765 Murcia, Spain.<br /><searchLink fieldCode="AU" term="%22Rivera+J%22">Rivera J</searchLink>; Servicio de Hematología y Oncología Médica, Hospital Universitario Morales Meseguer, Centro Regional de Hemodonación, Universidad de Murcia, IMIB-Pascual Parrilla, CIBERER-ISCIII, U765 Murcia, Spain.; Grupo Español de Alteraciones Plaquetarias Congénitas (GEAPC), Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Ramos-Mejia+V%22">Ramos-Mejia V</searchLink>; GENyO, Pfizer-Universidad de Granada-Junta de Andalucia Centre for Genomics and Oncological Research, PTS, Granada, Avenida de la Ilustracion 114, 18016 Granada, Spain.<br /><searchLink fieldCode="AU" term="%22Tersteeg+C%22">Tersteeg C</searchLink>; Laboratory for Thrombosis Research, IRF Life Sciences, KU Leuven Campus Kulak Kortrijk, Kortrijk, Belgium.<br /><searchLink fieldCode="AU" term="%22Real+PJ%22">Real PJ</searchLink>; GENyO, Pfizer-Universidad de Granada-Junta de Andalucia Centre for Genomics and Oncological Research, PTS, Granada, Avenida de la Ilustracion 114, 18016 Granada, Spain.; University of Granada, Department of Biochemistry and Molecular Biology I, Faculty of Science, Avenida Fuentenueva S/n, 18071 Granada, Spain.; Instituto de Investigación Biosanitaria Ibs.GRANADA, Granada, Spain. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101581621%22">Molecular therapy. Nucleic acids</searchLink> [Mol Ther Nucleic Acids] 2023 Jun 12; Vol. 33, pp. 75-92. <i>Date of Electronic Publication: </i>2023 Jun 12 (<i>Print Publication: </i>2023). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Cell+Press%22">Cell Press </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101581621 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>2162-2531 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2221622531%22">21622531 </searchLink><i>NLM ISO Abbreviation: </i>Mol Ther Nucleic Acids <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=37416759 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.omtn.2023.06.008 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 75 Titles: – TitleFull: Lentiviral gene therapy reverts GPIX expression and phenotype in Bernard-Soulier syndrome type C. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Martinez-Navajas G – PersonEntity: Name: NameFull: Ceron-Hernandez J – PersonEntity: Name: NameFull: Simon I – PersonEntity: Name: NameFull: Lupiañez P – PersonEntity: Name: NameFull: Diaz-McLynn S – PersonEntity: Name: NameFull: Perales S – PersonEntity: Name: NameFull: Modlich U – PersonEntity: Name: NameFull: Guerrero JA – PersonEntity: Name: NameFull: Martin F – PersonEntity: Name: NameFull: Sevivas T – PersonEntity: Name: NameFull: Lozano ML – PersonEntity: Name: NameFull: Rivera J – PersonEntity: Name: NameFull: Ramos-Mejia V – PersonEntity: Name: NameFull: Tersteeg C – PersonEntity: Name: NameFull: Real PJ IsPartOfRelationships: – BibEntity: Dates: – D: 12 M: 06 Text: 2023 Jun 12 Type: published Y: 2023 Identifiers: – Type: issn-print Value: 2162-2531 Numbering: – Type: volume Value: 33 Titles: – TitleFull: Molecular therapy. Nucleic acids Type: main |
| ResultId | 1 |